Melatonin Effects on Cardiovascular Disease Mechanisms in Midlife Women: A Randomized Clinical Trial
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age40-55
SponsorMayo Clinic
About this trial
The purpose of this research is to study the effects of 12 weeks of melatonin supplementation compared to placebo in women who are in the menopause transition (perimenopause) and have high blood pressure.
Eligibility criteria
Qualifiers
Age 40-55 years old
Female individuals with intact uterus and at least one ovary
Hypertension
On stable medical regimen (≥ 2 months) if taking other medications
Disqualifiers
Prescription sleeping medications or melatonin supplementation
Pregnant or lactating
Use of tobacco, nicotine or vaping products
Night shift work
Trial design
Treatments tested in this trial
- Terry Naturally® melatonin 5mg SR
- Placebo
Treatment groups
70 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov